Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ MAGED1 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA5102351
Description
Antibody detects endogenous levels of total MAGED1.
This gene is a member of the melanoma antigen gene (MAGE) family. Most of the genes of this family encode tumor specific antigens that are not expressed in normal adult tissues except testis. Although the protein encoded by this gene shares strong homology with members of the MAGE family, it is expressed in almost all normal adult tissues. This gene has been demonstrated to be involved in the p75 neurotrophin receptor mediated programmed cell death pathway. Three transcript variants encoding two different isoforms have been found for this gene.
Specifications
MAGED1 | |
Polyclonal | |
Unconjugated | |
MAGED1 | |
11B6; 2810433C11Rik; 5430405L04Rik; BCG-1; Dlixin; Dlxin1; DLXIN-1; DXBwg1492e; JCL-1; MAGE family member D1; MAGE tumor antigen CCF; MAGED1; MAGE-D1; MAGE-D1 antigen; Maged2; melanoma antigen family D, 1; melanoma antigen family D1; melanoma antigen, family D, 1; melanoma-associated antigen D1; mFLJ00163; neurotrophin receptor-interacting MAGE homolog; NRAGE; PP2250; PRO2292; Sertoli cell necdin-related gene protein 1; SNERG-1 | |
Rabbit | |
Affinity chromatography | |
RUO | |
84469, 94275, 9500 | |
-20°C | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot | |
1 mg/mL | |
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 | |
Q9ES73, Q9QYH6, Q9Y5V3 | |
MAGED1 | |
A synthesized peptide derived from human MAGED1(Accession Q9Y5V3), corresponding to amino acid residues D409-N459. | |
100 μL | |
Primary | |
Human, Mouse, Rat | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction